In respective AML mouse models for AML1-ETO and PML-RARα fusion proteins, which have decreased expression of HR factors, such as Rad51 and BRCA1, PARPi treatment was also beneficial [101]. The gene discussed is BRCA1; the disease is acute myeloid leukemia.